Exogenous glucocorticoids replace deficient cortisol, restoring negative feedback to the hypothalamus-pituitary-adrenal axis and reducing adrenocorticotropic hormone secretion, thereby inhibiting adrenal hyperplasia. This evidence concerns the gene POMC and congenital adrenal hyperplasia.